KEAP1 and Sepsis: Given this interaction, targeting these mechanisms with therapies like NF - κB pathway or KEAP1-NRF2/NFE2L2 pathway inhibitors, antioxidants targeting the products of the identified genes, or small – molecule oxidative stress response element modulators might enhance the prognosis of sepsis patients.